A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
Clinical trial NCT04826185 · COMPLETED
Trial details
- NCT number
- NCT04826185
- Sponsor
- Imbria Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2023-09-18
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.